Qingzhong Hu
Guangzhou University of Chinese Medicine(CN)Guangdong Pharmaceutical University(CN)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Estrogen and related hormone effects, Hormonal Regulation and Hypertension, Prostate Cancer Treatment and Research, Hormonal and reproductive studies
Most-Cited Works
- → CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents(2013)169 cited
- → Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17α-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure(2007)83 cited
- → Isopropylidene Substitution Increases Activity and Selectivity of Biphenylmethylene 4-Pyridine Type CYP17 Inhibitors(2010)73 cited
- → Novel CYP17 inhibitors: Synthesis, biological evaluation, structure–activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls(2009)70 cited
- → Selective Dual Inhibitors of CYP19 and CYP11B2: Targeting Cardiovascular Diseases Hiding in the Shadow of Breast Cancer(2012)68 cited
- → Novel Imidazol-1-ylmethyl Substituted 1,2,5,6-Tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as Potent and Selective CYP11B1 Inhibitors for the Treatment of Cushing’s Syndrome(2012)64 cited